Participate in a Study - Currently Recruiting

The Clinical Research Unit serves as a place where basic and clinical scientists work together to perform studies that incorporate translational research (the process of making research findings benefit patients) resulting in meaningful health outcomes. The Clinical Research Unit, along with skilled researchers and coordinators, will provide a welcoming and proficient setting for participants to volunteer in groundbreaking research studies.

BIOMEDICAL 

Genetic Testing of Obese Children and Adults 

—Andrea Haqq

Genes are often called “DNA” and are found in the body, making every individual different from anyone else. Some genes control things like the color of the hair or eyes. Other genes might make people more likely to weigh more. 

The purpose of this study is to identify people who have a rare genetic cause of obesity, who are 2 years of age or older. 

Participants will come to the University of Alberta for a one-hour visit. 

Participants will be asked questions about their health and appetite. Next, we will collect a blood sample from their arm. This screening test will identify individuals with one of three genetic variants (a change in the DNA structure) of the POMC, PCSK1 and LepR genes that is currently known to result in obesity. 

Inclusion criteria:

  • Evidence of hunger/hyperphagia at screening
  • Severe childhood obesity, preferably with past history evidence suggestive of onset prior to age 6 years at the time of identification

For more information please contact:  Lucila at triador@ualberta.ca
Sponsored by Rhythm Pharmaceuticals, Inc.


NN9828-4150 Study

Effect of NNC0114-006 and liraglutide on preservation of beta cell function in adults with newly diagnosed Type 1 diabetes
—Peter Senior/Novo Nordisk

Phase 2 drug trial for patients who have been newly diagnosed with Type 1 diabetes (within the past 5 months)

Contact the ADI Clinical Research Unit for more information or for prescreening:
Amanda Perreault   780-492-1098    adicru@ualberta.ca
Caroline Lyster       780-­248-­1770    clyster@ualberta.ca


GLARGL07699 Study

Effect of switching from a twice-daily injection of basal insulin to a once-daily injection of ToujeoTM in adults with Type 1 diabetes

– Peter Senior/sanofi-aventis Canada Inc

Post-marketing drug trial for patients with Type 1 diabetes who use a twice-daily injection of basal insulin.

Contact the ADI Clinical Research Unit for more information or for prescreening:
Amanda Perreault   780-492-1098    adicru@ualberta.ca
Caroline Lyster       780-­248-­1770    clyster@ualberta.ca


NUTRITION

Polycystic Ovary Syndrome (PCOS) Clinical Trial

—Donna Vine

  • Women with a diagnosis of Polycystic Ovary Syndrome
  • Overweight or obese
  • 18-30 years old 
  • Exclusion Criteria: Pregnancy, lactating, taking oral contraceptives or medication that influences metabolism (eg statins)

For more information please contact:

PCOStudy@ualberta.ca
Stara Morning (Study Coordinator)       780-238-5111
Donna Vine    (Principle Investigator)   780-492-4393


The Alberta FYBER Study (Feed Your Gut Bacteria More FIber)

—Jens Walter

  • A randomized control trial studying the role of fiber in gut health 
  • Healthy males or females ages 19-45 years old with a BMI between 25-35
  • Participants will be asked to add pre-packaged fiber to their diet daily for a period of six weeks

For more information please contact:
uafyber@ualberta.ca or 780-492-9506  

PHYSICAL ACTIVITY

The VIGOR Trial

A study examining the effects of physical fitness on glycemic responses to high intensity exercise in type 1 diabetes.

—Jane Yardley

Males and females with type 1 diabetes:

  • between the ages of 15 and 35
  • regularly participating in vigorous endurance exercise (> or equal to 3 times/week for >1 year)
  • having an HbA1c < 9.9%


For more information please contact: 
Jane Yardley  jane.yardley@ualberta.ca


Blood Glucose Responses to Resistance Exercise in Type 1 Diabetes

Males and females with type 1 diabetes:
  • Between the ages of 18 and 50 
  • Regularly performing physical activity at least three times/week
  • Having HbA1c < 9.9%
For more information please contact: 
Jane Yardley  jane.yardley@ualberta.ca

Impact of exercise during pregnancy on blood pressure control study

—Margie Davenport

  • Less than 20 weeks pregnant
For more information or to volunteer please contact: 
pregnant@ualberta.ca or phone 780-492-0642  www.exerciseandpregnancy.ca

Blood Pressure Regulation During Pregnancy 

—Margie Davenport

  • Recruiting women with either 1) normal blood pressure 2) gestational hypertension 3) preeclampsia or 4) gestational diabetes
  • Testing occurs after 28 weeks 

For more information or to volunteer please contact: 
pregnant@ualberta.ca or phone 780-492-0642  www.exerciseandpregnancy.ca 

E-PAraDiGM: Exercise-Physical Activity Diabetes Glucose Monitoring Protocol 

  • Men and women with type 2 diabetes   
  • 30-90 years of age   
  • HbA1c < 9%   
  • Able to walk for 45 minutes    
For more information contact Jordan Rees rees@ualberta.ca



Join our participant database

Interested in participating in research, but don’t qualify for any of our current studies? 
Sign up for our general database using our Google form

Your information will be entered into our database, and researchers may contact you about participation in future research studies at the Alberta Diabetes Institute.